site stats

Halozyme share price

WebHalozyme Therapeutics Inc (HALO) Common Stock USD0.001. Halozyme Therapeutics Inc (HALO) Sell: $32.18 Buy: $38.36 $0.88 (2.36%) Market closed Prices as at close on 31 March 2024 Turn off ... WebApr 6, 2024 · The average twelve-month price prediction for Halozyme Therapeutics is $56.33 with a high price target of $68.00 and a low price target of $42.00. Learn more on …

Halozyme Therapeutics, Inc. (HALO) Stock Price Today, Quote

WebHalozyme Therapeutics, Inc. (HALO) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 38.33 +0.90 (+2.40%) At close: 04:00PM EDT. 38.63 +0.30 … Find the latest Halozyme Therapeutics, Inc. (HALO) stock discussion in Yahoo … Halozyme Therapeutics, Inc. 12390 El Camino Real San Diego, CA 92130 … Find out all the key statistics for Halozyme Therapeutics, Inc. (HALO), including … See Halozyme Therapeutics, Inc. (HALO) stock analyst estimates, including … Interactive Chart for Halozyme Therapeutics, Inc. (HALO), analyze all … Discover historical prices for HALO stock on Yahoo Finance. View daily, weekly or … View the basic HALO option chain and compare options of Halozyme … See Halozyme Therapeutics, Inc. (HALO) Environment, Social and Governance … Find out the direct holders, institutional holders and mutual fund holders for … Find the latest Halozyme Therapeutics, Inc. (HALO) stock quote, history, news and … WebApr 13, 2024 · SVB Leerink downgraded shares of Halozyme Therapeutics from an “outperform” rating to a “market perform” rating and set a $42.00 price target on the stock. in a report on Thursday, March 16th. iberley horas extras https://matthewdscott.com

Halozyme Therapeutics Inc. (HALO) Stock Price Today, News, …

Web23 hours ago · Halozyme Therapeutics Inc. HALO, +1.20% stock fell in the extended session Tuesday after the biotech drug maker's 2024 forecast disappointed Wall Street. … WebWells Fargo Adjusts Halozyme Therapeutics' Price Target to $55 From $65, Keeps Overweight Rating. MT Newswires. 03/16 10:01. SVB Securities Downgrades Halozyme … WebHistorical daily share price chart and data for Halozyme Therapeutics since 2024 adjusted for splits. The latest closing stock price for Halozyme Therapeutics as of April 06, 2024 is 38.33.. The all-time high Halozyme Therapeutics stock closing price was 59.44 on December 02, 2024.; The Halozyme Therapeutics 52-week high stock price is 59.46, … monarto safari park wild africa

HALO - Halozyme Therapeutics Inc Stock Price Quote

Category:Park Avenue Securities LLC Buys 1,077 Shares of Halozyme …

Tags:Halozyme share price

Halozyme share price

HALO Price Target 2024 Halozyme Therapeutics Analyst Ratings

WebFeb 6, 2024 · Halozyme Therapeutics, Inc. (NASDAQ:HALO) shareholders might be concerned after seeing the share price drop 17% in the last quarter. But in stark contrast, the returns over the last half decade ... WebApr 10, 2024 · Wells Fargo & Company reduced their price target on shares of Halozyme Therapeutics from $65.00 to $55.00 and set an “overweight” rating on the stock in a research report on Thursday, March 16th.

Halozyme share price

Did you know?

WebFeb 26, 2024 · The signified lack of projected business resulted in a salient downturn, with HALO opening price on January 10th valuing at $55.7, and concluding at $50.56. Since then, stock valuation has ... WebHalozyme Therapeutics (HALO) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Support: 888-992 …

WebOct 1, 2024 · Halozyme Therapeutics is low risk biotech with steadily increasing revenue. ... HALO share price touched $50 in February and April 2024 but has since declined to near $40 where it has hovered for ... WebIn terms of dividends, Halozyme Therapeutics Inc has a dividend per share of 0 and a dividend yield of 0. The company's most recent dividend date was None, and the ex-dividend date was None. HALO's financials reveal a book value of 1.256 and earnings per share (EPS) of 1.44, with a diluted EPS (TTM) of 1.44.

WebView the latest Halozyme Therapeutics Inc. (HALO) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebApr 10, 2024 · On Friday 04/07/2024 the closing price of the Halozyme Therapeutics Inc. share was $38.33 on NAS. Compared to the opening price on Friday 04/07/2024 on …

WebGet Halozyme Therapeutics Inc (HALO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

WebAug 8, 2024 · It might be of some concern to shareholders to see the Halozyme Therapeutics, Inc. (NASDAQ:HALO) share price down 13% in the last month. But in stark contrast, the returns over the last half ... iberley noticiasWebHistorical daily share price chart and data for Halozyme Therapeutics since 2024 adjusted for splits. The latest closing stock price for Halozyme Therapeutics as of April 06, 2024 … iberley fiscalWebApr 13, 2024 · The company has a market cap of $4.92 billion, a price-to-earnings ratio of 25.06, a price-to-earnings-growth ratio of 0.57 and a beta of 1.22. Halozyme Therapeutics, Inc. has a 12-month low of $32.83 and a 12-month high of $59.46. The company has a quick ratio of 4.88, a current ratio of 5.65 and a debt-to-equity ratio of 8.79. iberley horas complementariasWebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Halozyme Therapeutics Inc.’s P/E ratio is 25.63. iberley lecWebApr 4, 2024 · HALOZYME THERAPEUTICS, INC. : Trading strategies, financial analysis, commentaries and investment guidance for HALOZYME THERAPEUTICS, INC. Stock Nasdaq: HALO Nasdaq iberley opinionesWebFeb 21, 2024 · During 2024, the Company repurchased a total of 4.5 million shares for $200 million at an average price per share of $44.44, and as of December 31, 2024, Halozyme has completed $350 million of its ... iberley ineptitud sobrevenidaWebApr 11, 2024 · Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. ... Market capitalization is … iberley permiso paternidad 2022